Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC8 substrates: Histones and beyond
Noah A. Wolfson, Carol Ann Pitcairn, Carol A. Fierke
Biopolymers (2012) Vol. 99, Iss. 2, pp. 112-126
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti, Ina Oehme, Olaf Witt, et al.
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 7, pp. 481-492
Open Access | Times Cited: 242
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Alokta Chakrabarti, Jelena Melesina, Fiona R. Kolbinger, et al.
Future Medicinal Chemistry (2016) Vol. 8, Iss. 13, pp. 1609-1634
Open Access | Times Cited: 95
The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes
Michele Gabriele, Alejandro Tobon, Giuseppe D’Agostino, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 84, pp. 306-327
Open Access | Times Cited: 90
Transcription and beyond: the role of mammalian class I lysine deacetylases
M. Moser, Astrid Hagelkrüys, Christian Seiser
Chromosoma (2013) Vol. 123, Iss. 1-2, pp. 67-78
Open Access | Times Cited: 93
Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
David E. Olson, Florence F. Wagner, Taner Kaya, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 11, pp. 4816-4820
Closed Access | Times Cited: 82
Common non-epigenetic drugs as epigenetic modulators
Jörn Lötsch, Gisbert Schneider, Daniel Reker, et al.
Trends in Molecular Medicine (2013) Vol. 19, Iss. 12, pp. 742-753
Closed Access | Times Cited: 80
An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8
David E. Olson, Namrata D. Udeshi, Noah A. Wolfson, et al.
ACS Chemical Biology (2014) Vol. 9, Iss. 10, pp. 2210-2216
Open Access | Times Cited: 76
Development of a Potent and Selective HDAC8 Inhibitor
O.J. Ingham, Ronald M. Paranal, William Smith, et al.
ACS Medicinal Chemistry Letters (2016) Vol. 7, Iss. 10, pp. 929-932
Open Access | Times Cited: 67
Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6
G.R. Vanaja, Hemalatha Golaconda Ramulu, Arunasree M. Kalle
Cell Communication and Signaling (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 61
Structural Basis of Catalysis and Inhibition of HDAC6 CD1, the Enigmatic Catalytic Domain of Histone Deacetylase 6
J.D. Osko, D.W. Christianson
Biochemistry (2019) Vol. 58, Iss. 49, pp. 4912-4924
Open Access | Times Cited: 59
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Anna Fontana, Ilaria Cursaro, Gabriele Carullo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10014-10014
Open Access | Times Cited: 30
Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
Sk. Abdul Amin, Samima Khatun, Shovanlal Gayen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115594-115594
Closed Access | Times Cited: 19
Compromised Structure and Function of HDAC8 Mutants Identified in Cornelia de Lange Syndrome Spectrum Disorders
Christophe Decroos, Christine M. Bowman, J. Moser, et al.
ACS Chemical Biology (2014) Vol. 9, Iss. 9, pp. 2157-2164
Open Access | Times Cited: 63
HDAC8 inhibition ameliorates pulmonary fibrosis
Shigeki Saito, Yan Zhuang, Takayoshi Suzuki, et al.
AJP Lung Cellular and Molecular Physiology (2018) Vol. 316, Iss. 1, pp. L175-L186
Open Access | Times Cited: 58
HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
Gonzalo Lopez, Kate Lynn J. Bill, Hemant K. Bid, et al.
PLoS ONE (2015) Vol. 10, Iss. 7, pp. e0133302-e0133302
Open Access | Times Cited: 55
Variable Active Site Loop Conformations Accommodate the Binding of Macrocyclic Largazole Analogues to HDAC8
Christophe Decroos, Dane J. Clausen, Brandon E. Haines, et al.
Biochemistry (2015) Vol. 54, Iss. 12, pp. 2126-2135
Open Access | Times Cited: 55
Structure-Based Identification of HDAC8 Non-histone Substrates
Nawsad Alam, Lior Zimmerman, Noah A. Wolfson, et al.
Structure (2016) Vol. 24, Iss. 3, pp. 458-468
Open Access | Times Cited: 51
A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation
Lena Hess, Verena Moos, Arnel A. Lauber, et al.
PLoS Genetics (2022) Vol. 18, Iss. 8, pp. e1010376-e1010376
Open Access | Times Cited: 26
Non-sirtuin histone deacetylases in the control of cardiac aging
Bradley S. Ferguson, Timothy A. McKinsey
Journal of Molecular and Cellular Cardiology (2015) Vol. 83, pp. 14-20
Open Access | Times Cited: 49
Histone deacetylases and atherosclerosis
Xiaxia Zheng, Tian Zhou, Xinan Wang, et al.
Atherosclerosis (2014) Vol. 240, Iss. 2, pp. 355-366
Closed Access | Times Cited: 49
Biochemical and Structural Characterization of HDAC8 Mutants Associated with Cornelia de Lange Syndrome Spectrum Disorders
Christophe Decroos, Nicolas Christianson, Laura E. Gullett, et al.
Biochemistry (2015) Vol. 54, Iss. 42, pp. 6501-6513
Open Access | Times Cited: 47
RNA oxidation in chromatin modification and DNA-damage response following exposure to formaldehyde
Juan C. Gonzalez‐Rivera, Mark W. Sherman, Dongyu Wang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
Salma Darwish, Ehab Ghazy, Tino Heimburg, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7535-7535
Open Access | Times Cited: 22
Unveiling critical structural features for effective HDAC8 inhibition: a comprehensive study using quantitative read-across structure–activity relationship (q-RASAR) and pharmacophore modeling
Samima Khatun, Indrasis Dasgupta, Rakibul Islam, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
Mechanistic Underpinnings of Epigenetic Enzyme-Responsive Nanoparticles
Raj Shankar Hazra, Debasmita Dutta, Md Rakib Hasan Khan, et al.
ACS Applied Bio Materials (2025)
Closed Access
Page 1 - Next Page

Scroll to top